Idorsia Company

Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
Technology:
Small Molecules
Industry:
BioTech
Headquarters:
Allschwil
Founded Date:
2017
Employees Number:
501-1000
Total Funding:
$1.4B
Register and Claim Ownership